Cellectis S.A. Interest Expense 2011-2026 | CLLS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Cellectis S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	371 K	368 K	73 K	3 K	39 K	-	-	1 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
371 K	1 K	142 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	16.5 M	$ 12.32	-0.24 %	$ 3.86 B	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	443 K	$ 23.27	-1.63 %	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.36	-2.16 %	$ 362 M	Britain
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.76	4.35 %	$ 9.05 B	Australia
CymaBay Therapeutics CBAY	18.9 M	-	-	$ 3.45 B	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	-512 K	$ 2.57	-3.38 %	$ 16.1 M	USA
Avid Bioservices CDMO	4.34 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	5.81 M	-	-	$ 1.41 B	USA
Checkpoint Therapeutics CKPT	344 K	-	-	$ 169 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	-309 K	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	13.1 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	354 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	16.4 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	293 K	-	-	$ 2.02 B	USA
Dyadic International DYAI	250 K	$ 0.88	1.66 %	$ 31.8 M	USA
BioNTech SE BNTX	14.2 M	$ 89.62	-1.82 %	$ 27.2 B	Germany
Coherus BioSciences CHRS	9 M	$ 1.67	-	$ 196 M	USA
Akari Therapeutics, Plc AKTX	100 K	$ 3.8	7.34 %	$ 256 B	Britain
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA